news
A CRISPR gene editing technique has been developed to restore…
12 May 2021 | By Victoria Rees (Drug Target Review)
A CRISPR gene editing technique has been developed to restore dystrophin, which is missing in many Duchenne muscular dystrophy (DMD) patients.